X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Curaleaf products display at Curaleaf store in Queens in New York, U.S., on Thursday, Oct.18, 2018. (Photo: Jeenah Moon/Bloomberg) Curaleaf products display at Curaleaf store in Queens in New York, U.S., on Thursday, Oct.18, 2018. (Photo: Jeenah Moon/Bloomberg)

Federal regulators last Tuesday threatened cannabis giant Curaleaf with possible legal action for allegedly making unsubstantiated medical claims about the cannabidiol, or CBD, products on its website and on social media.

In a public letter, the U.S. Food and Drug Administration gave Massachusetts-based Curaleaf about two weeks to explain what it has done to correct alleged violations, including website claims that CBD has “properties that counteract the growth of spread of cancer” and is “linked to the effective treatment of Alzheimer’s disease.”

Want to continue reading?
Become a Free
PropertyCasualty360 Digital Reader.

INCLUDED IN A DIGITAL MEMBERSHIP:

  • All PropertyCasualty360.com news coverage, best practices, and in-depth analysis.
  • Educational webcasts, resources from industry leaders, and informative newsletters.
  • Other award-winning websites including BenefitsPRO.com and ThinkAdvisor.com.

Already have an account?

PropertyCasualty360

Join PropertyCasualty360

Don’t miss crucial news and insights you need to make informed decisions for your P&C insurance business. Join PropertyCasualty360.com now!

  • Unlimited access to PropertyCasualty360.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including BenefitsPRO.com, ThinkAdvisor.com and Law.com
  • Exclusive discounts on PropertyCasualty360, National Underwriter, Claims and ALM events

Already have an account? Sign In Now
Join PropertyCasualty360

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.